Maksaev G, Yuan P, and Nichols CG
Category: Nichols CG
Glucokinase Inhibition: A Novel Treatment for Diabetes? (Links to an external site)
Remedi MS, and Nichols CG
Conformational plasticity of NaK2K and TREK2 potassium channel selectivity filters (Links to an external site)
Matamoros M, Ng XW, Brettmann JB, Piston DW, and Nichols CG
Personalized therapeutics for KATP-dependent pathologies (Links to an external site)
Nichols CG
A unique high-output cardiac hypertrophy phenotype arising from low systemic vascular resistance in Cantu Syndrome (Links to an external site)
Singh GK, McClenaghan C, Aggarwal M, Gu H, Remedi MS, Grange DK, and Nichols CG
Genome-edited zebrafish model of ABCC8 loss-of-function disease (Links to an external site)
Ikle JM, Tryon RC, Singareddy SS, York NW, Remedi MS, and Nichols CG
KATP channels in lymphatic function (Links to an external site)
Davis MJ, Kim HJ, and Nichols CG
ATP-sensitive potassium channels in hyperinsulinism and type 2 diabetes: Inconvenient paradox or new paradigm? (Links to an external site)
Nichols CG, York NW, and Remedi MS
Isolation of cardiac and vascular smooth muscle cells from adult, juvenile, larval and embryonic zebrafish for electrophysiological studies (Links to an external site)
Singareddy SS, McClenaghan C, Roessler HI, Tryon R, and Nichols CG
Bridging personal and population in excitability diseases: Will studies of rare diseases bring generalizable mechanisms from monogenic channelopathies? (Links to an external site)
Nichols CG, and McClenaghan C